Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?

By Yahoo! Finance   |   2 years ago
Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?

Eli Lilly has seen success with its weight loss drugs, Mounjaro and Zepbound. Viking Therapeutics is an emerging competitor, with promising clinical trial results for its weight loss candidate, VK2735. Viking's oral formulation could offer a convenient alternative.

Read More

Did you find this insightful?